News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
78,450 Results
Type
Article (972)
Company Profile (12)
Press Release (77466)
Section
Business (21267)
Career Advice (129)
Deals (8329)
Drug Development (6714)
Employer Resources (2)
FDA (1328)
Job Trends (1561)
News (38159)
Policy (2766)
Tag
Academia (88)
Accelerated approval (3)
Allergies (2)
Alliances (5942)
ALS (11)
Alzheimer's disease (161)
Antibody-drug conjugate (ADC) (19)
Approvals (1386)
Artificial intelligence (26)
Autoimmune disease (7)
Automation (3)
Bankruptcy (84)
Best Places to Work (1392)
Biosimilars (29)
Biotechnology (9)
Bladder cancer (9)
Brain cancer (11)
Breast cancer (53)
Cancer (477)
Cardiovascular disease (23)
Career advice (110)
CAR-T (20)
Celiac Disease (1)
Cell therapy (56)
Cervical cancer (3)
Clinical research (6054)
Collaboration (120)
Compensation (58)
Complete response letters (4)
COVID-19 (104)
CRISPR (1)
C-suite (71)
Cystic fibrosis (11)
Data (616)
Depression (10)
Diabetes (31)
Diagnostics (742)
Digital health (5)
Diversity, equity & inclusion (1)
Drug discovery (17)
Drug pricing (5)
Duchenne muscular dystrophy (12)
Earnings (7865)
Employer branding (1)
Employer resources (2)
Events (10835)
Executive appointments (127)
FDA (1626)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (164)
Gene editing (6)
Gene therapy (11)
GLP-1 (29)
Government (192)
Guidances (46)
Healthcare (2000)
IgA nephropathy (2)
Immunology and inflammation (10)
Immuno-oncology (7)
Indications (10)
Infectious disease (119)
Inflammatory bowel disease (28)
Influenza (9)
Intellectual property (42)
Interviews (23)
IPO (4920)
Job creations (208)
Job search strategy (93)
JPM (1)
Layoffs (8)
Legal (904)
Liver cancer (4)
Lung cancer (64)
Lymphoma (26)
Machine learning (2)
Manufacturing (46)
MASH (13)
Medical device (1865)
Medtech (1869)
Mergers & acquisitions (3851)
Metabolic disorders (73)
Multiple sclerosis (9)
NASH (1)
Neurodegenerative disease (20)
Neuropsychiatric disorders (5)
Neuroscience (282)
NextGen: Class of 2026 (905)
Non-profit (167)
Obesity (30)
Opinion (3)
Ovarian cancer (18)
Pain (22)
Pancreatic cancer (49)
Parkinson's disease (39)
Partnered (3)
Patents (80)
Patient recruitment (41)
Peanut (2)
People (6742)
Pharmacy benefit managers (3)
Phase 1 (1877)
Phase 2 (2808)
Phase 3 (1966)
Pipeline (569)
Policy (2)
Postmarket research (146)
Preclinical (733)
Press Release (1)
Prostate cancer (19)
Psychedelics (2)
Radiopharmaceuticals (48)
Rare diseases (56)
Real estate (529)
Recruiting (1)
Regulatory (2064)
Reports (6)
Research institute (140)
Resumes & cover letters (15)
RSV (6)
Schizophrenia (33)
Series A (21)
Series B (19)
Sickle cell disease (16)
Spinal muscular atrophy (3)
Startups (497)
State (1)
Stomach cancer (1)
Supply chain (8)
Vaccines (37)
Weight loss (5)
Women's health (5)
Date
Last 7 days (61)
Last 30 days (211)
Last 365 days (3484)
2026 (293)
2025 (3540)
2024 (4448)
2023 (5504)
2022 (6750)
2021 (7861)
2020 (7572)
2019 (5280)
2018 (4091)
2017 (3921)
2016 (3234)
2015 (4532)
2014 (3096)
2013 (2534)
2012 (2711)
2011 (2366)
2010 (2114)
Location
Africa (22)
Alabama (6)
Arizona (44)
Arkansas (1)
Asia (3792)
Australia (504)
California (1390)
Canada (230)
China (64)
Colorado (41)
Connecticut (81)
Delaware (30)
Europe (5532)
Florida (278)
Georgia (37)
Idaho (7)
Illinois (99)
India (2)
Indiana (85)
Japan (25)
Kansas (19)
Kentucky (7)
Louisiana (3)
Maine (45)
Maryland (177)
Massachusetts (839)
Michigan (72)
Minnesota (76)
Mississippi (4)
Missouri (19)
Montana (2)
Nebraska (4)
Nevada (38)
New Hampshire (14)
New Jersey (431)
New Mexico (2)
New York (440)
North Carolina (284)
Northern California (557)
Ohio (41)
Oregon (3)
Pennsylvania (345)
Rhode Island (4)
South America (65)
South Carolina (11)
Southern California (625)
Tennessee (45)
Texas (374)
United States (5406)
Utah (62)
Vermont (1)
Virginia (46)
Washington D.C. (2)
Washington State (89)
West Virginia (1)
Wisconsin (23)
78,450 Results for "sekisui xenotech llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SEKISUI Diagnostics Announces Launch of the OSOM® RSV Test
May 21, 2025
·
2 min read
Press Releases
SEKISUI Diagnostics to Provide Metrix® COVID/Flu Test to the Point-of-Care and Home Test Markets
April 3, 2025
·
3 min read
Press Releases
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
December 17, 2025
·
3 min read
Genetown
SEKISUI Diagnostics Receives Emergency Use Authorization for the OSOM® Flu SARS-CoV-2 Combo Test
SEKISUI Diagnostics, a global medical diagnostics manufacturer, has received EUA clearance for the OSOM Flu SARS-CoV-2 Combo Test for use in professional and home testing settings.
March 5, 2024
·
2 min read
Press Releases
Kathy Spencer-Pike Joins NorthStar Medical Radioisotopes, LLC as Chief Commercial Officer
December 17, 2025
·
3 min read
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Press Releases
SEKISUI Completes £15.7 Million Expansion in cGMP Biopharma CDMO Capacity
November 15, 2024
·
2 min read
SEKISUI CHEMICAL CO., LTD. and RevolKa Signed a Contract Research Agreement
RevolKa Ltd., a venture-backed biotech company providing a game-changing protein engineering technology platform signed a contract research agreement with SEKISUI CHEMICAL CO., LTD..
January 23, 2024
·
2 min read
Press Releases
Curonix LLC Announces Commercial Availability of the Freedom® Peripheral Nerve Stimulator (PNS) System as the Only Full-Body PNS Therapy Available in the United States for Craniofacial Pain
January 19, 2026
·
3 min read
BioIVT Acquires XenoTech, a Leading Provider of Products and Services for Preclinical Testing of New Drug Candidates
BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that it has acquired XenoTech, a provider of products for ADME-Tox in vitro models and contract research services, from Sekisui Chemical, based in Japan.
September 12, 2022
·
3 min read
1 of 7,845
Next
